MAPT and tauopathy: Transgenic mice expressing tau35 recapitulated key features of human tauopathies, including aggregated and abnormally phosphorylated tau, progressive motor and cognitive deficits, autophagic and lysosomal dysfunction, loss of synaptic protein and reduced life-span [41].